Review
doi: 10.3109/07357909509024932.
The cell cycle as therapeutic target
Affiliations
- PMID: 7583713
- DOI: 10.3109/07357909509024932
Item in Clipboard
Review
The cell cycle as therapeutic target
Cancer Invest.
1995.
Abstract
Approved by the FDA in 1991 with indications for acceleration of neutrophil recovery in several clinical settings, CSFs may prove clinically useful in ways beyond hemorestoration. Myeloprotection conferred by GM-CSF may enable higher doses of chemotherapy to be given with only short intervals between cycles. Priming may make resting AML blasts more chemosensitive. Mobilization of peripheral blood stem cells may facilitate and even improve autologous stem cell transplantation.
Similar articles
-
The potential for the use of colony-stimulating factors in autologous bone marrow transplantation.Recent Results Cancer Res. 1991;121:182-8. doi: 10.1007/978-3-642-84138-5_20. Recent Results Cancer Res. 1991. PMID: 1713337 Review. No abstract available.
-
Use and toxicity of the colony-stimulating factors.Drug Saf. 1993 Jun;8(6):457-68. doi: 10.2165/00002018-199308060-00006. Drug Saf. 1993. PMID: 7687134 Review.
-
Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.Acta Haematol. 1990;84(4):175-81. doi: 10.1159/000205058. Acta Haematol. 1990. PMID: 2125781
-
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001. Biol Blood Marrow Transplant. 2004. PMID: 15148493 Clinical Trial.
-
Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.Cancer. 1994 Apr 1;73(7):1960-70. doi: 10.1002/1097-0142(19940401)73:7<1960::aid-cncr2820730730>3.0.co;2-h. Cancer. 1994. PMID: 7511042
Cited by
-
Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules?J Exp Med. 1996 Jun 1;183(6):2411-5. doi: 10.1084/jem.183.6.2411. J Exp Med. 1996. PMID: 8676060 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
